Identity
- Security key
- 19753
- Ticker
- OSTX
- Type
- CS — Common Stock
- Exchange
- NYSE American, LLC(XASE)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2024-08-01
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- OSTX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $73,457,578.25
- Shares outstanding (class)
- 45,538,101
- Shares outstanding (weighted)
- 45,625,825
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 5
- Location
- ROCKVILLE, MD
- Homepage
- https://www.ostherapies.com
- Description
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The company's mission is to address the need for new treatments in cancers of the bone in children and young adults. The company has pipeline of product candidates targeting multiple indications for solid cancers including two drug technologies: (i) OST-HER2, an off-the-shelf immunotherapy, which is a type of cancer treatment that helps the immune system fight cancer and OST-tADC which is a tunable drug conjugate (tADC) platform currently in preclinical development. Each tADC contains four main components: ligand, payload cassette adaptor, linker and payload.